Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Puma Biotechnology stock

Learn how to easily invest in Puma Biotechnology stock.

Puma Biotechnology Inc is a biotechnology business based in the US. Puma Biotechnology shares (PBYI) are listed on the NASDAQ and all prices are listed in US Dollars. Puma Biotechnology employs 196 staff and has a trailing 12-month revenue of around $206.9 million.

How to buy shares in Puma Biotechnology

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PBYI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Puma Biotechnology stock price (NASDAQ: PBYI)

Use our graph to track the performance of PBYI stocks over time.

Puma Biotechnology shares at a glance

Information last updated 2022-09-26.
Latest market close$2.37
52-week range$1.60 - $7.73
50-day moving average $2.98
200-day moving average $2.72
Wall St. target price$5.40
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.19

Buy Puma Biotechnology shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Puma Biotechnology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Puma Biotechnology price performance over time

Historical closes compared with the close of $2.37 from 2022-09-30

1 week (2022-09-26) 4.41%
1 month (2022-09-02) -8.14%
3 months (2022-07-01) -14.75%
6 months (2022-04-01) -20.47%
1 year (2021-10-01) -63.37%
2 years (2020-10-02) -76.08%
3 years (2019-10-03) 10.23
5 years (2017-10-03) 117

Is Puma Biotechnology stock undervalued or overvalued?

Valuing Puma Biotechnology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Puma Biotechnology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Puma Biotechnology's PEG ratio

Puma Biotechnology's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.03. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Puma Biotechnology's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Puma Biotechnology's EBITDA

Puma Biotechnology's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $18.4 million.

The EBITDA is a measure of a Puma Biotechnology's overall financial performance and is widely used to measure a its profitability.

Puma Biotechnology financials

Revenue TTM $206.9 million
Operating margin TTM 4.44%
Gross profit TTM $209.5 million
Return on assets TTM 2.53%
Return on equity TTM -140.14%
Profit margin -16.67%
Book value $0.44
Market capitalisation $107.1 million

TTM: trailing 12 months

Puma Biotechnology share dividends

We're not expecting Puma Biotechnology to pay a dividend over the next 12 months.

Puma Biotechnology share price volatility

Over the last 12 months, Puma Biotechnology's shares have ranged in value from as little as $1.6 up to $7.73. A popular way to gauge a stock's volatility is its "beta".

PBYI.US volatility(beta: 0.67)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Puma Biotechnology's is 0.6684. This would suggest that Puma Biotechnology's shares are less volatile than average (for this exchange).

Puma Biotechnology overview

Puma Biotechnology, Inc. , a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc. ; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd. , CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc. , Pierre Fabre Medicament SAS, and Bixink Therapeutics Co.

Frequently asked questions

What percentage of Puma Biotechnology is owned by insiders or institutions?
Currently 13.965% of Puma Biotechnology shares are held by insiders and 63.095% by institutions.
How many people work for Puma Biotechnology?
Latest data suggests 196 work at Puma Biotechnology.
When does the fiscal year end for Puma Biotechnology?
Puma Biotechnology's fiscal year ends in December.
Where is Puma Biotechnology based?
Puma Biotechnology's address is: 10880 Wilshire Boulevard, Los Angeles, CA, United States, 90024
What is Puma Biotechnology's ISIN number?
Puma Biotechnology's international securities identification number is: US74587V1070
What is Puma Biotechnology's CUSIP number?
Puma Biotechnology's Committee on Uniform Securities Identification Procedures number is: 74587V107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site